VWF and cancer: Notably, a significant rise in the plasma levels of VWF has been demonstrated in patients with malignant disease compared to benign conditions and healthy controls (p<0.005), with an even greater increase seen in patients with disseminated disease compared to early stage cancer (p<0.0001) [58].